|
KMID : 1039420220560030170
|
|
Journal of Pathology and Translational Medicine
2022 Volume.56 No. 3 p.170 ~ p.171
|
|
|
What’s new in breast pathology 2022: WHO 5th edition and biomarker updates
|
|
Muller Kristen
Jorns Julie M.
Tozbikian Gary
|
|
|
Abstract
|
|
|
|
The 5th edition WHO Classification of Breast Tumours (2019) has introduced changes to our practices. Highlights are presented below, with a focus on modifications to morphological subtype categorization. In addition, we summarize important updates to ER and PR testing made in the 2020 ASCO/CAP guidelines, and briefly discuss PD-L1 and Ki-67 testing in breast cancer.
|
|
|
KEYWORD
|
|
|
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|